BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17852454)

  • 1. Rapid transformation of atypical myeloproliferative disorder with consistent t(8;13) to B-cell acute lymphoblastic leukemia: a case report.
    Sahin F; Sercan Z; Ertan Y; Ocakci S; Ay E; Vural F; Yuksel E; Tombuloglu M; Saydam G
    Hematology; 2007 Dec; 12(6):489-92. PubMed ID: 17852454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biphenotypic hematologic malignancy: a case report of the 8p11 myeloproliferative syndrome in a child.
    Chen X; Zhang Y; Li Y; Lei P; Zhai Y; Liu L
    J Pediatr Hematol Oncol; 2010 Aug; 32(6):501-3. PubMed ID: 20562652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [8p11 myeloproliferative syndrome].
    Li F; Zhai YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):1073-7. PubMed ID: 23998615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome.
    Xiao S; Nalabolu SR; Aster JC; Ma J; Abruzzo L; Jaffe ES; Stone R; Weissman SM; Hudson TJ; Fletcher JA
    Nat Genet; 1998 Jan; 18(1):84-7. PubMed ID: 9425908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 8p11 myeloproliferative syndrome: a review.
    Jackson CC; Medeiros LJ; Miranda RN
    Hum Pathol; 2010 Apr; 41(4):461-76. PubMed ID: 20226962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential transformation of t(8;13)-related disease: a case report.
    Roy S; Szer J; Campbell LJ; Juneja S
    Acta Haematol; 2002; 107(2):95-7. PubMed ID: 11919389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fourth case of 8p11 myeloproliferative disorder transforming to B-lineage acute lymphoblastic leukaemia. A case report.
    JabbarAl-Obaidi M; Rymes N; White P; Pomfret M; Smith H; Starczynski J; Johnson R
    Acta Haematol; 2002; 107(2):98-100. PubMed ID: 11919390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1.
    Macdonald D; Reiter A; Cross NC
    Acta Haematol; 2002; 107(2):101-7. PubMed ID: 11919391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase.
    Montenegro-Garreaud X; Miranda RN; Reynolds A; Tang G; Wang SA; Yabe M; Wang W; Fang L; Bueso-Ramos CE; Lin P; Medeiros LJ; Lu X
    Hum Pathol; 2017 Jul; 65():147-156. PubMed ID: 28551329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular monitoring of 8p11 myeloproliferative syndrome in an infant.
    Zhang WW; Habeebu S; Sheehan AM; Naeem R; Hernandez VS; Dreyer ZE; López-Terrada D
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):879-83. PubMed ID: 19829149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical pathological features of the 8p11 myeloproliferative syndrome].
    Yan Z; Yang B; Wang QS; Wang LL; Han XP; Ren F; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1321-6. PubMed ID: 21129285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder.
    Chen J; Deangelo DJ; Kutok JL; Williams IR; Lee BH; Wadleigh M; Duclos N; Cohen S; Adelsperger J; Okabe R; Coburn A; Galinsky I; Huntly B; Cohen PS; Meyer T; Fabbro D; Roesel J; Banerji L; Griffin JD; Xiao S; Fletcher JA; Stone RM; Gilliland DG
    Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14479-84. PubMed ID: 15448205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloproliferative disorders with t(8;9)(p12;q33): a case report and review of the literature.
    Hu S; He Y; Zhu X; Li J; He H
    Pediatr Hematol Oncol; 2011 Mar; 28(2):140-6. PubMed ID: 21214407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical and gene involved of one case of 8p11 myeloproliferative syndrome with ins(13;8)(q12;p11p23)].
    Zhou F; Chen S; Chao H; Zhang R; Zhou M; Pan J
    Zhonghua Xue Ye Xue Za Zhi; 2015 Apr; 36(4):291-6. PubMed ID: 25916288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome.
    Reiter A; Sohal J; Kulkarni S; Chase A; Macdonald DH; Aguiar RC; Gonçalves C; Hernandez JM; Jennings BA; Goldman JM; Cross NC
    Blood; 1998 Sep; 92(5):1735-42. PubMed ID: 9716603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal evolution of 8p11 stem cell syndrome in a 14-year-old Chinese boy: a review of literature of t(8;13) associated myeloproliferative diseases.
    Wong WS; Cheng KC; Lau KM; Chan NP; Shing MM; Cheng SH; Chik KW; Li CK; Ng MH
    Leuk Res; 2007 Feb; 31(2):235-8. PubMed ID: 16777224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 14-3-3 Integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1-transformed hematopoietic cells.
    Dong S; Kang S; Gu TL; Kardar S; Fu H; Lonial S; Khoury HJ; Khuri F; Chen J
    Blood; 2007 Jul; 110(1):360-9. PubMed ID: 17389761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1.
    Walz C; Chase A; Schoch C; Weisser A; Schlegel F; Hochhaus A; Fuchs R; Schmitt-Gräff A; Hehlmann R; Cross NC; Reiter A
    Leukemia; 2005 Jun; 19(6):1005-9. PubMed ID: 15800673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-lymphoblastic leukemia/lymphoma associated with t(8;13)(p11;q12)/ ZMYM2 (ZNF198)-FGFR1 : rare case and review of the literature.
    Trimaldi J; Carballido EM; Bowers JW; Anguiano AL; Zhang ZJ; Shah BD; Bruno S; List AF; Moscinski LC; Grady T; Agosti SJ; Kang L; Zhang L
    Acta Haematol; 2013; 130(3):127-34. PubMed ID: 23594707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of 8p11 myeloproliferative syndrome with BCR-FGFR1 gene fusion presenting with trilineage acute leukemia/lymphoma, successfully treated by cord blood transplantation.
    Morishige S; Oku E; Takata Y; Kimura Y; Arakawa F; Seki R; Imamura R; Osaki K; Hashiguchi M; Yakushiji K; Mizuno S; Yoshimoto K; Nagafuji K; Ohshima K; Okamura T
    Acta Haematol; 2013; 129(2):83-9. PubMed ID: 23171834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.